Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma

Clinical trial NCT01178658 · UNKNOWN

Trial details

NCT number: NCT01178658
Sponsor: Seoul National University Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma

Start date: 2010-07-01
Primary completion: 2014-12-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.